한글목차

세계의 바이오 분석 시험 서비스 시장 규모는 2022년 29억 달러, 2023년 32억 달러에서 예측기간 중 15.2%의 CAGR로 성장하여 2028년에는 66억 달러 규모로 성장할 것으로 예측됩니다.

서비스 종류별로는 세포 기반 어세이 부문이 2022년 5억 7,250만 달러, 2023년 6억 5,300만 달러에서 15.7%의 CAGR로 성장하여 2028년에는 14억 달러 규모로 성장할 것으로 예측됩니다. 또한 생물학적 동등성 및 생체이용률 연구 부문은 2022년 5억 2,360만 달러, 2023년 5억 9,750만 달러에서 16.3%의 CAGR로 성장하여 2028년에는 13억 달러 규모로 성장할 것으로 예측됩니다.

세계의 바이오 분석 시험 서비스 시장을 조사했으며, 시장 및 기술 개요, 시장 영향요인 분석, 규제 상황, 시장 규모 추정과 예측, 각종 부문·지역별 상세 분석, 기술 및 특허 동향, ESG 전개, 경쟁 상황, 주요 기업 개요 등을 정리했습니다.

목차

제1장 서론

제2장 요약과 하이라이트

• 시장 전망
• 시장 요약

제3장 시장 개요

• 기술 배경
• 액체 크로마토그래피 질량 분석(LC-MS)
• 유도 결합 플라즈마 질량 분석(ICP-MS)
• 핵자기공명(NMR)
• 모세관 전기영동(CE)
• 가스 크로마토그래피 질량 분석(GC-MS)

제4장 시장 역학

• 시장 역학
• 성장 촉진요인
• 성장 억제요인
• 기회
• COVID-19가 바이오 분석 시험 서비스 시장에 미치는 영향
• 규제 상황
• PESTEL 분석
• 의약품 바이오 분석의 성공요인
• 고성능 기기에 대한 투자
• 최신 기술의 지속적 평가
• 용량 증가 시험이 환자 안전에 미치는 영향
• 규제 환경의 변화

제5장 세계의 바이오 분석 시험 서비스 시장 : 서비스 유형별

• 약물동태 연구
• 생물학적 동등성 및 생체이용률 연구
• 바이오마커 검사 서비스
• 세포 기반 어세이
• 바이러스 검사
• 방법 개발, 최적화, 검증
• 혈청학, 면역원성, 중화 항체
• 기타

제6장 세계의 바이오 분석 시험 서비스 시장 : 용도별

• 종양
• 심혈관질환
• 면역
• 신경내과
• 감염증
• 기타

제7장 세계의 바이오 분석 시험 서비스 시장 : 최종사용자별

• 제약회사 및 바이오의약품 회사
• CRO
• CDMO
• 기타

제8장 세계의 바이오 분석 시험 서비스 시장 : 지역별

• 북미
• 유럽
• 아시아태평양
• 기타 지역

제9장 ESG 전개

• ESG : 서론
• 바이오 분석 시험 서비스 업계에서 ESG의 중요성
• ESG 평가와 지표 : 데이터 이해
• 바이오 분석 시험 서비스 업계의 ESG 실천
• 환경면 퍼포먼스
• 사회면 퍼포먼스
• 지배구조면 퍼포먼스
• 향후 동향
• BCC에 의한 견해

제10장 새로운 기술과 개발

• 새로운 기술
• 바이오 분석 샘플 조제 기술의 최근 개발

제11장 M&A 분석

제12장 경쟁 정보

• 주요 기업 순위
• 기업이 채용하는 주요 전략
• 확대
• 신제품 발매
• 협업
• 기타

제13장 기업 개요

• AFFIGENIX BIOSOLUTIONS PVT LTD
• ALMAC GROUP
• ARAGEN LIFE SCIENCES PVT LTD
• BIOANALYTICAL SYSTEMS INC.
• BIONEEDS INDIA PRIVATE LTD
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
• EUROFINS SCIENTIFIC SE
• INOTIV INC.(ENVIGO)
• INTERTEK GROUP PLC
• LABORATORY CORP. OF AMERICA HOLDINGS
• PACE ANALYTICAL
• PACIFIC BIOLABS
• SARTORIUS AG
• SGS S.A.
• SYNEOS HEALTH
• WUXI APPTEC CO. LTD

영문목차

Highlights:

The global bioanalytical testing services market reached $2.9 billion in 2022, should reach $3.2 billion by 2023 and $6.6 billion by 2028 with a compound annual growth rate (CAGR) of 15.2% during the forecast period of 2023-2028.

Cell-Based Assays segment of the global bioanalytical testing services market reached $572.5 million in 2022, should reach $653.0 million by 2023 and $1.4 billion by 2028 with a CAGR of 15.7% during the forecast period of 2023-2028.

Bioequivalence & Bioavailability Studies segment of the global bioanalytical testing services market reached $523.6 million in 2022, should reach $597.5 million by 2023 and $1.3 billion by 2028 with a CAGR of 16.3% during the forecast period of 2023-2028.

Report Scope:

The report's scope includes an overview of the global market on bioanalytical testing services and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.

The report analyzes leading services, applications, end user, and product details for the bioanalytical testing services market. Leading market players' profiles, specific services, financial information, and recent market activities are provided. This report also assesses companies' mergers & acquisitions and funding activities and their impact in the face of the competitive environment. The report details the bioanalytical testing services market based on service type, application, and end user. The market is segmented into pharmacokinetics studies, bioequivalence and bioavailability studies, biomarker testing services, cell-based assays, virology testing, method development, optimization & validation, serology, immunogenicity, and neutralizing antibodies, and others.

The market is categorized as oncology, immunology, neurology, infectious diseases, cardiovascular diseases, and others. The market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, contract development and manufacturing organizations, and others. The report also consists of the impact of the COVID-19 pandemic on this market. Regional analysis includes North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the World (South America, and the Middle East and Africa).

Report Includes:

• 45 data tables and 44 additional tables
• An overview of the global market for bioanalytical testing services
• An estimate of market size and analyses of global market trends, with data from 2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2028
• Characterization and quantification of the global market for bioanalytical testing services on the basis of technology, application, end user and region
• Information on sample requirements for discovery bioanalysis, preclinical and clinical bioanalysis and descriptions of toxicokinetic and pharmacokinetics studies
• Coverage of technological advances in the drug discovery process and information on investments in the R&D of biologics, biosimilars and other specialty drugs
• An examination of the drivers and constraints that will shape the market, and a discussion of the upcoming market opportunities in order to forecast the market by its segments and sub-segments
• An assessment of existing products as well as those in the pipelines of the major players in the market
• Coverage of recent advances, emerging technologies and ongoing developments in the industry
• An evaluation of key industry acquisitions and strategic alliances, and an analysis of the market shares of the leading companies
• Company profiles of major players within the industry, including SGS S.A., Intertek Group PLC, Eurofins Scientific SE, Charles River International Laboratories, Inc., Inotiv Inc., and WuXi AppTec

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Methodology
• Information Sources
• Geographic Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Summary

Chapter 3 Market Overview

• Introduction
• Technology Background
• Liquid Chromatography-Mass Spectrometry (LC-MS)
• Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
• Nuclear Magnetic Resonance (NMR)
• Capillary Electrophoresis (CE)
• Gas Chromatography-Mass Spectrometry (GC-MS)

Chapter 4 Market Dynamics

• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Impact of COVID-19 on the Bioanalytical Testing Services Market
• Regulatory Landscape
• PESTEL Analysis
• Success Factors in Pharmaceutical Bioanalysis
• Investing in High Capability Equipment
• Constant Evaluation of the Latest Technologies
• Considering the Impact of Rising Dose Trials on Patient Safety
• Keeping a Track of Changes in Regulatory Environment

Chapter 5 Global Bioanalytical Testing Services Market by Service Type

• Pharmacokinetics Studies
• Bioequivalence and Bioavailability Studies
• Biomarker Testing Services
• Cell-Based Assays
• Virology Testing
• Method Development, Optimization & Validation
• Serology, Immunogenicity, and Neutralizing Antibodies
• Others

Chapter 6 Global Bioanalytical Testing Services Market by Application

• Oncology
• Cardiovascular Diseases
• Immunology
• Neurology
• Infectious Diseases
• Others

Chapter 7 Global Bioanalytical Testing Services Market by End User

• Pharmaceutical and Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Contract Development and Manufacturing Organizations (CDMOs)
• Others

Chapter 8 Global Bioanalytical Testing Services Market by Region

• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 9 ESG Developments

• Introduction to ESG
• Importance of ESG in Bioanalytical Testing Services Industry
• ESG Ratings and Metrics: Understanding the Data
• ESG practices in the Bioanalytical Testing Services Industry
• Environmental Performance
• Social Performance
• Governance Performance
• Future Trends
• BCC Research Viewpoint

Chapter 10 Emerging Technologies and Developments

• Emerging Technologies
• Recent Developments in Bioanalytical Sample Preparation Techniques

Chapter 11 M&A Analysis

• M&A Analysis

Chapter 12 Competitive Intelligence

• Top Market Players Ranking, 2022
• Key Strategies Adopted by Companies
• Expansion
• New Product Launch
• Collaboration
• Others

Chapter 13 Company Profiles

• AFFIGENIX BIOSOLUTIONS PVT LTD
• ALMAC GROUP
• ARAGEN LIFE SCIENCES PVT LTD
• BIOANALYTICAL SYSTEMS INC.
• BIONEEDS INDIA PRIVATE LTD
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
• EUROFINS SCIENTIFIC SE
• INOTIV INC. (ENVIGO)
• INTERTEK GROUP PLC
• LABORATORY CORP. OF AMERICA HOLDINGS
• PACE ANALYTICAL
• PACIFIC BIOLABS
• SARTORIUS AG
• SGS S.A.
• SYNEOS HEALTH
• WUXI APPTEC CO. LTD